INCOME STATEMENT
Tatva Chintan Pharma Chem Ltd.
BSE
Apr 30
706.00
-17.85 ( -2.47%)
Volume
1880
Prev. Close
723.85
Open Price
719.20
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
704.50
-19.05 ( -2.63%)
Volume
14765
Prev. Close
723.55
Open Price
727.40
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE0GK401011
|
Market Cap. ( ₹ in Cr. )
|
1647.97
|
P/BV
|
2.23
|
Book Value ( ₹ )
|
315.32
|
|
BSE Code
|
543321
|
52 Week High/Low ( ₹ )
|
1284/621
|
FV/ML
|
10/1
|
P/E(X)
|
54.29
|
|
NSE Code
|
TATVAEQ
|
Book Closure
|
20/09/2024
|
EPS ( ₹ )
|
12.98
|
Div Yield (%)
|
0.28
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 375.67 | 400.32 | 425.46 | 287.69 | 249.44 |
| Other Operating Revenues | 3.01 | 2.72 | 2.35 | 3.50 | 4.41 |
| Total Operating Revenues | 378.68 | 403.04 | 427.81 | 291.19 | 253.84 |
| | | | | | |
| Other Income | 7.51 | 5.68 | 10.51 | 5.10 | 0.56 |
| Total Revenue | 386.19 | 408.72 | 438.32 | 296.29 | 254.40 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 178.76 | 215.82 | 254.49 | 150.91 | 146.16 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -10.72 | 6.51 | -58.04 | -5.20 | -16.03 |
| Employee Benefit Expenses | 54.76 | 38.60 | 30.81 | 24.13 | 20.53 |
| Finance Costs | 6.51 | 8.38 | 4.83 | 4.21 | 3.94 |
| Depreciation And Amortisation Expenses | 25.60 | 9.55 | 8.18 | 6.73 | 4.79 |
| Other Expenses | 89.01 | 87.44 | 94.77 | 56.16 | 50.80 |
| Total Expenses | 343.92 | 366.30 | 335.05 | 236.94 | 210.19 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 42.27 | 42.42 | 103.27 | 59.35 | 44.22 |
| | | | | | |
| Exceptional Items | 0.00 | -3.59 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 42.27 | 38.83 | 103.27 | 59.35 | 44.22 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 7.34 | 1.96 | 18.01 | 10.37 | 7.44 |
| Deferred Tax | 5.57 | -3.59 | -10.73 | -2.38 | 1.15 |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.66 |
| Total Tax Expenses | 12.92 | -1.63 | 7.28 | 7.99 | 9.25 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 29.35 | 40.47 | 95.99 | 51.36 | 34.96 |
| | | | | | |
| Profit/Loss From Continuing Operations | 29.35 | 40.47 | 95.99 | 51.36 | 34.96 |
| | | | | | |
| Profit/Loss For The Period | 29.35 | 40.47 | 95.99 | 51.36 | 34.96 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 12.82 | 18.26 | 44.65 | 25.57 | 17.41 |
| Diluted EPS (Rs.) | 12.82 | 18.26 | 44.65 | 25.57 | 17.41 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 4.68 | 4.43 | 0.00 | 4.02 | 0.00 |
| Equity Dividend Rate (%) | 20.00 | 20.00 | 20.00 | 50.00 | 0.00 |